Michael (Mike) Garrison has been named executive vice president (EVP) and president of the Medical segment, and Richard (Rick) Byrd has been named executive vice president (EVP) and president of the Interventional segment, both effective Sept. 6.
Brighter AB [publ], today published its second quarter interim report for April – June 2022. The full report is available on the company website https://brighter.se. The report is also attached to this press release as a PDF file.
Novo Nordisk Education Foundation (NNEF) and Roche Diabetes Care India (RDC) today signed a Memorandum of Understanding (MoU) to improve access to care for underprivileged children living with Type 1 diabetes (T1D) in India. This partnership is part of a global collaboration between the two parties and will impact close to 4,000 children with Type 1 diabetes in India. It will also provide education and training for doctors and nurses, and enhance awareness about diabetes and its management among children with T1D and their families.
Teladoc Health the global leader in whole-person virtual care, together with Cloud DX, a leading remote patient monitoring ("RPM") platform, are pleased to announce that they have entered into a strategic partnership to better serve the remote monitoring needs of patients across Canada.
#rpm
#virtual care
Hygieia, a provider of digital therapeutics for insulin management, has added Metro Detroit Endocrinology Center in Dearborn as a clinical partner. The partnership extends Hygieia’s d-Nav® network and makes autonomous insulin therapy service available for an underserved population.
#product & service
#dtx
DreaMed Diabetes a developer of expert-level AI-based diabetes care solutions, partners with Billings Clinic to deploy its endo.digital clinical decision support system. Through the partnership, providers in the Billings Clinic network can now access DreaMed’s endo.digital platform, an FDA-cleared clinical decision support system built to aid insulin-dosing optimization for Type 1 and Type 2 diabetes patients.
#product & service
Researchers at NuraLogix, a global leader in HealthTech AI, announced that they have developed AI models that can predict a person’s risk of HbA1C levels and Fasting Blood Glucose levels being above a significant clinical threshold for pre-diabetes
Ypsomed added a new mylife Dose feature in its mylife App fore remote bolus delivery
#insulin pump
To investigate the accuracy of the Dexcom G6 during physical activity
#cgm
Senseonics Holdings, Inc., a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced its Chief Financial Officer, Nick Tressler, is transitioning from his position, effective September 1, 2022.